Company
ExcepGen
Unlocking more tolerable RNA medicines
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- San Francisco, CA, United States
Claim, correct or request removal
Record updated 28 September 2026
About
RNA based vaccines with tolerability close to the standard of care by dampening an excessive innate immune response
Products
- Other
- RNAx
Loading relationship preview